Shares in Accuray (NSDQ:ARAY) rose today after the medical device maker beat expectations on Wall Street with its fourth quarter and full fiscal year 2018 earnings. The Sunnyvale, Calif.-based company posted losses of $946,000 or 1¢ per share, on sales of $113.8 million for the three months ended June 30, seeing losses shrink 82% while sales […]
7 medtech stories we missed this week: June 22, 2018
From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in […]
Accuray shares down on Q3 EPS miss, growing losses
Shares in Accuray (NSDQ:ARAY) have fallen today after the medical device maker missed EPS expectations on Wall Street with its fiscal year 2018 third quarter earnings results. The Sunnyvale, Calif.-based company posted losses of $8.9 million, or 10¢ per share, on sales of $99.8 million for the three months ended March 31, seeing losses grow 76% […]
Accuray touts trigeminal neuralgia CyberKnife study results
Accuray (NSDQ:ARAY) today released data from a study exploring the use of its CyberKnife system used in stereotactic radiosurgery procedures for patients with trigeminal neuralgia, touting rapid and long-lasting pain relief with minimal side effects. Results from the study were published in the journal Neurosurgery, the Sunnyvale, Calif.-based company said. “This study is important because it reinforces […]
Accuray shares rise on FY2018 Q2 EPS beat
Shares in Accuray (NSDQ:ARAY) have risen today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings results. The Sunnyvale, Calif.-based company posted losses of $4.7 million, or 6¢ per share, on sales of $100.3 million, seeing losses shrink 49.6% while sales grew 14.7% compared with the same period during the […]
Accuray pulls the trigger on Series A convertible senior note buyback
Accuray (NSDQ:ARAY) said yesterday it made an irrevocable net share settlement election for its 3.5% Series A convertible senior notes due February 1, 2018, looking to pay cash up to $1,000 for each $1,000 principal amount of Series A notes converted alongside delivery of shares for the conversion value in excess of $1,000. The Sunnyvale, Calif.-based […]
Accuray to use $40m term loan to retire senior debt
Accuray (NSDQ:ARAY) said today that it plans to use the $40 million term loan it just took out from MidCap Financial Trust to buy back some of its senior debt notes and lower the amount of its credit revolver with MidCap. Sunnyvale, Calif.-based Accuray, which makes radiosurgery devices, said it plans to use the term loan […]
These 10 medtech companies care a lot about research
Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in […]
Accuray wins FDA nod for iDMS data management system
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its iDMS data management system designed for sharing data between the company’s treatment delivery platforms. The Sunnyvale, Calif.-based company said the iDMS system is designed to integrate data from its technology platforms, including the Radixact, TomoTherapy and CyberKnife systems, as well as the company’s Accuray Precision […]
Accuray touts study data in head-to-head between TomoTherapy and Varian’s RapidArc
Accuray (NSDQ:ARAY) today released data from a prospective study comparing its TomoTherapy intensity-modulated radiation therapy system with Varian Medical‘s (NYSE:VAR), RapidArc radiotherapy system, touting a higher survival rate for patients treated with its TomoTherapy system. Results from the study were published last month in the International Journal of Radiation Oncology – Biology – Physics. Accuray said that […]
Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017
Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]
- 1
- 2
- 3
- …
- 10
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+